199 related articles for article (PubMed ID: 35881893)
1. Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial.
Imam SS; El-Farrash RA; Taha AS; Saleh GA
J Cardiovasc Pharmacol; 2022 Nov; 80(5):746-752. PubMed ID: 35881893
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial.
El-Ghandour M; Hammad B; Ghanem M; Antonios MAM
Paediatr Drugs; 2020 Dec; 22(6):685-693. PubMed ID: 32856285
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of inhaled versus infused milrinone in the management of persistent pulmonary hypertension of the newborn in resource-limited settings: A randomized clinical trial.
Choobdar FA; Shahhosseini P; Vahedi Z; Khosravi N; Khalesi N; Ghassemzadeh M
Pediatr Pulmonol; 2023 Jul; 58(7):2132-2139. PubMed ID: 37133219
[TBL] [Abstract][Full Text] [Related]
4. Management of neonatal pulmonary hypertension-a survey of neonatal intensive care units in India.
Singh P; Deshpande S; Nagpal R; Garegrat R; Gupta S; Suryawanshi P
BMC Pediatr; 2023 Mar; 23(1):149. PubMed ID: 37004003
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil for pulmonary hypertension in neonates.
Kelly LE; Ohlsson A; Shah PS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005494. PubMed ID: 28777888
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants with, or at Risk of, Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial.
Pierce CM; Zhang MH; Jonsson B; Iorga D; Cheruvu N; Balagtas CC; Steinhorn RH
J Pediatr; 2021 Oct; 237():154-161.e3. PubMed ID: 34052232
[TBL] [Abstract][Full Text] [Related]
7. Outcome of oral sildenafil in neonatal persistent pulmonary hypertension of non-cardiac causes.
Sayed A; Bisheer N
J Neonatal Perinatal Med; 2015; 8(3):215-20. PubMed ID: 26485555
[TBL] [Abstract][Full Text] [Related]
8. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study.
Baquero H; Soliz A; Neira F; Venegas ME; Sola A
Pediatrics; 2006 Apr; 117(4):1077-83. PubMed ID: 16585301
[TBL] [Abstract][Full Text] [Related]
9. Persistent pulmonary hypertension of the newborn: therapeutical approach.
Latini G; Del Vecchio A; De Felice C; Verrotti A; Bossone E
Mini Rev Med Chem; 2008 Dec; 8(14):1507-13. PubMed ID: 19075808
[TBL] [Abstract][Full Text] [Related]
10. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn.
McNamara PJ; Laique F; Muang-In S; Whyte HE
J Crit Care; 2006 Jun; 21(2):217-22. PubMed ID: 16769471
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil for pulmonary hypertension in neonates.
Shah PS; Ohlsson A
Cochrane Database Syst Rev; 2007 Jul; (3):CD005494. PubMed ID: 17636802
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Persistent Pulmonary Hypertension of the Newborn: Use of Pulmonary Vasodilators in Term Neonates.
Luecke C; McPherson C
Neonatal Netw; 2017 May; 36(3):160-168. PubMed ID: 28494828
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil for pulmonary hypertension in neonates.
Shah PS; Ohlsson A
Cochrane Database Syst Rev; 2011 Aug; (8):CD005494. PubMed ID: 21833954
[TBL] [Abstract][Full Text] [Related]
14. Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study.
Al Omar S; Salama H; Al Hail M; Al Rifai H; Bunahia M; El Kasem W; Siddiqui FJ; Dilawar M; Yassin H; Masud F; Mohamed A; Mansour A
J Neonatal Perinatal Med; 2016 Sep; 9(3):251-9. PubMed ID: 27589542
[TBL] [Abstract][Full Text] [Related]
15. Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health.
Khorana M; Yookaseam T; Layangool T; Kanjanapattanakul W; Paradeevisut H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S64-73. PubMed ID: 22043756
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
Lakshminrusimha S; Mathew B; Leach CL
Semin Perinatol; 2016 Apr; 40(3):160-73. PubMed ID: 26778236
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of oral sildenafil for neonates with persistent pulmonary hypertension of newborn (PPHN): a prospective study in a tertiary care hospital.
Kamran A; Rafiq N; Khalid A; Amin F; Kumari V; Shaikh AS; Tebha SS; Patel N
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6787-6793. PubMed ID: 33980104
[TBL] [Abstract][Full Text] [Related]
18. Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial.
Chetan C; Suryawanshi P; Patnaik S; Soni NB; Rath C; Pareek P; Gupta B; Garegrat R; Verma A; Singh Y
BMC Pediatr; 2022 May; 22(1):311. PubMed ID: 35624452
[TBL] [Abstract][Full Text] [Related]
19. Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.
Lakshminrusimha S; Konduri GG; Steinhorn RH
J Perinatol; 2016 Jun; 36 Suppl 2():S12-9. PubMed ID: 27225960
[TBL] [Abstract][Full Text] [Related]
20. Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn.
Kahveci H; Yilmaz O; Avsar UZ; Ciftel M; Kilic O; Laloglu F; Ozturk K
Pediatr Pulmonol; 2014 Dec; 49(12):1205-13. PubMed ID: 24420987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
